GlassScriptPhysician profile
David J Petersen
NPI 1942250808
$3,810.95
in general payments reported to CMS, 2019-2025
14 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $811 · 2021: $784 · 2022: $427 · 2023: $393 · 2024: $181 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,145.26 | 2019-2020 | |
| Smith+Nephew, INC. | $1,127.66 | 2019-2023 | Memofix Super Elastic Nitinol Staple System |
| Stryker Corporation | $668.19 | 2019-2025 | Prophecy, Augment Injectable, Prostep |
| Paragon 28, INC. | $279.17 | 2019-2025 | Bun-Yo-Matic |
| Treace Medical Concepts, INC. | $210.63 | 2023-2024 | |
| Abbott Laboratories | $149.78 | 2023 | Eterna |
| Cardiovascular Systems INC. | $68.87 | 2022 | |
| Tactile Systems Technology INC | $57.85 | 2020-2021 | |
| Medtronic, INC. | $26.02 | 2024 | Intellis Adaptivestim |
| Zimmer Biomet Holdings, INC. | $22.62 | 2019 | |
| Ossio INC | $15.94 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.48 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $14.96 | 2019 | |
| Bard Peripheral Vascular, INC. | $8.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.